NCLEX Review Guide: Shock & Critical Condition Management

Types of Shock

• Hypovolemic Shock: Results from significant fluid loss leading to inadequate cardiac output and tissue perfusion. Common causes include hemorrhage, severe dehydration, burns, and excessive diuresis.
• Cardiogenic Shock: Occurs when the heart fails to pump effectively, resulting in decreased cardiac output despite adequate blood volume. Primary causes include myocardial infarction, cardiomyopathy, and valvular disorders.
• Distributive Shock: Characterized by peripheral vasodilation and reduced systemic vascular resistance. Subdivided into septic shock (infection-induced), anaphylactic shock (severe allergic reaction), and neurogenic shock (loss of sympathetic tone).
• Obstructive Shock: Results from physical obstruction to blood flow, preventing adequate cardiac output. Causes include pulmonary embolism, cardiac tamponade, and tension pneumothorax.

Stages of Shock

• Initial/Compensatory Stage: Body attempts to maintain perfusion through sympathetic nervous system activation. Characterized by tachycardia, mild hypotension, anxiety, and cool, pale extremities.
• Progressive Stage: Compensatory mechanisms begin to fail, resulting in worsening tissue hypoxia. Manifestations include decreasing blood pressure, increasing tachycardia, altered mental status, and decreased urine output.
• Irreversible Stage: Cellular and tissue damage becomes so severe that death is inevitable despite treatment. Features include profound hypotension, bradycardia, anuria, and unresponsiveness.

Clinical Manifestations

• Cardiovascular Signs: Tachycardia (early) or bradycardia (late), hypotension, weak/thready pulse, decreased pulse pressure, and dysrhythmias. MAP (Mean Arterial Pressure) less than 65 mmHg indicates inadequate tissue perfusion.
• Respiratory Signs: Tachypnea, respiratory alkalosis (early), respiratory acidosis (late), and decreased oxygen saturation. Changes in respiratory pattern may indicate worsening shock state.
• Neurological Signs: Altered mental status ranging from anxiety and restlessness to confusion, lethargy, and eventual unresponsiveness. Mental status changes are sensitive indicators of cerebral perfusion.
• Renal Signs: Oliguria (urine output <0.5 mL/kg/hr) or anuria, indicating decreased renal perfusion. Urine output is a critical marker for assessing tissue perfusion and treatment effectiveness.
• Integumentary Signs: Cool, clammy skin (except in warm shock states like early septic shock), delayed capillary refill (>3 seconds), and cyanosis in advanced stages.

Diagnostic Studies

• Laboratory Values: CBC (decreased Hgb/Hct in hemorrhagic shock), electrolytes, BUN/creatinine (elevated in renal hypoperfusion), lactate levels (elevated >2 mmol/L indicates tissue hypoxia), coagulation studies, and blood cultures (for suspected sepsis).
• Arterial Blood Gases: Initially shows respiratory alkalosis (from tachypnea); progresses to metabolic acidosis (from anaerobic metabolism) with respiratory compensation; late stages show combined respiratory and metabolic acidosis.
• Hemodynamic Monitoring: Central venous pressure (CVP), pulmonary artery pressure, cardiac output, and systemic vascular resistance measurements help differentiate shock types and guide fluid management.
• Imaging Studies: Chest X-ray (for cardiac enlargement, pulmonary edema, pneumothorax), echocardiography (for cardiac function, tamponade), CT scans (for identifying sources of bleeding or infection).

General Management Principles

• Airway Management: Ensure patent airway; administer oxygen to maintain SpO2 >94%; intubation and mechanical ventilation may be necessary for respiratory distress or decreased consciousness.
• Circulatory Support: Establish large-bore IV access (preferably two); administer crystalloid fluids (balanced solutions preferred over normal saline) for volume resuscitation; consider blood products for hemorrhagic shock.
• Monitoring: Continuous cardiac monitoring, frequent vital signs, hourly urine output measurement, serial lactate levels, and central venous pressure monitoring in severe cases.
• Positioning: Place patient in supine position with legs elevated 30° (modified Trendelenburg) if hypotensive, unless contraindicated. This position increases venous return to the heart.

Specific Interventions by Shock Type

1. Hypovolemic Shock Management:
   • Rapid fluid resuscitation with isotonic crystalloids (20-30 mL/kg initially)
   • Blood product administration for hemorrhagic shock (target Hgb >7-9 g/dL)
   • Identify and control source of fluid loss (apply direct pressure to external bleeding sites)
   • Consider surgical intervention for internal hemorrhage
2. Cardiogenic Shock Management:
   • Cautious fluid administration (avoid volume overload)
   • Inotropic agents (dobutamine) to improve cardiac contractility
   • Vasopressors (norepinephrine) to maintain adequate blood pressure
   • Treatment of underlying cause (PCI for MI, valvular repair)
   • Consider mechanical circulatory support (IABP, Impella, ECMO) for refractory cases
3. Septic Shock Management:
   • Early broad-spectrum antibiotics within 1 hour of recognition
   • Source control (drainage of abscesses, removal of infected devices)
   • Aggressive fluid resuscitation (30 mL/kg crystalloid within first 3 hours)
   • Vasopressors if hypotension persists after fluid resuscitation (norepinephrine first-line)
   • Consider hydrocortisone (200-300 mg/day) for refractory shock
4. Anaphylactic Shock Management:
   • Immediate epinephrine administration (0.3-0.5 mg IM in anterolateral thigh)
   • Airway management (early intubation if signs of airway compromise)
   • IV fluids for hypotension
   • Adjunctive therapies: antihistamines, corticosteroids, albuterol for bronchospasm
   • Identify and remove allergen if possible
5. Neurogenic Shock Management:
   • Maintain spinal immobilization if spinal injury suspected
   • Judicious fluid administration
   • Vasopressors with both alpha and beta activity (norepinephrine preferred)
   • Atropine for symptomatic bradycardia
   • Corticosteroids for acute spinal cord injury (controversial)
6. Obstructive Shock Management:
   • Tension pneumothorax: Immediate needle decompression followed by chest tube placement
   • Cardiac tamponade: Pericardiocentesis
   • Pulmonary embolism: Thrombolytics for massive PE, anticoagulation, possible embolectomy

Vasopressors & Inotropes

• Norepinephrine (Levophed): First-line vasopressor for most shock states. Strong alpha-1 and moderate beta-1 effects increase SVR and maintain cardiac output. Dosage: 0.01-3 mcg/kg/min titrated to MAP ≥65 mmHg.
• Epinephrine: Potent alpha and beta agonist used in anaphylactic shock and as second-line in septic shock. Dosage: 0.01-0.5 mcg/kg/min IV infusion (1:10,000 solution); 0.3-0.5 mg IM (1:1,000 solution) for anaphylaxis.
• Dopamine: Dose-dependent effects: 1-5 mcg/kg/min (dopaminergic, increases renal blood flow), 5-10 mcg/kg/min (beta-1, increases cardiac output), >10 mcg/kg/min (alpha-1, increases SVR). Less commonly used due to increased arrhythmia risk.
• Dobutamine: Primarily beta-1 agonist that increases cardiac contractility with minimal effect on SVR. Used in cardiogenic shock. Dosage: 2.5-20 mcg/kg/min.
• Vasopressin: Non-catecholamine vasopressor that causes vasoconstriction via V1 receptors. Used as adjunct in refractory septic shock. Dosage: 0.01-0.04 units/min.
• Phenylephrine (Neo-Synephrine): Pure alpha-1 agonist that increases SVR without chronotropic effects. Useful in neurogenic shock or when tachyarrhythmias limit use of other vasopressors. Dosage: 0.5-9 mcg/kg/min.

Fluid Therapy

• Crystalloids: First-line fluid therapy for most shock states. Balanced solutions (Lactated Ringer's, PlasmaLyte) preferred over normal saline to prevent hyperchloremic metabolic acidosis. Initial bolus: 20-30 mL/kg.
• Colloids: Include albumin, dextran, and synthetic colloids (hydroxyethyl starch). More expensive than crystalloids with no proven survival benefit in most cases. Albumin 5% may be considered in septic shock after initial crystalloid resuscitation.
• Blood Products: Packed red blood cells (PRBCs) indicated for hemorrhagic shock (target Hgb 7-9 g/dL). Fresh frozen plasma (FFP), platelets, and cryoprecipitate used for coagulopathy. Massive transfusion protocols typically use 1:1:1 ratio of PRBCs:FFP:platelets.

Ongoing Assessment & Monitoring

• Vital Signs: Continuous cardiac monitoring, blood pressure every 5-15 minutes until stable, then every 30-60 minutes. Monitor for trends rather than isolated readings. Target MAP ≥65 mmHg or higher in patients with chronic hypertension.
• Tissue Perfusion Assessment: Monitor skin color, temperature, capillary refill, level of consciousness, and hourly urine output (target >0.5 mL/kg/hr). These parameters provide critical information about end-organ perfusion.
• Hemodynamic Parameters: In critically ill patients, monitor central venous pressure (CVP), central venous oxygen saturation (ScvO2), cardiac output, and systemic vascular resistance if available. ScvO2 >70% indicates adequate oxygen delivery.
• Laboratory Monitoring: Serial lactate levels (clearance indicates improved perfusion), ABGs, electrolytes, BUN/creatinine, liver function tests, coagulation studies, and CBC. Trend these values to assess response to treatment.
• Fluid Balance: Strict intake and output monitoring, daily weights, and assessment for signs of fluid overload (crackles, S3 heart sound, JVD, peripheral edema, increasing oxygen requirements).

Nursing Interventions

• IV Access & Management: Maintain at least two large-bore IV catheters (16-18 gauge) or central venous access. Use pressure bags or rapid infusers for fluid resuscitation. Monitor IV sites for infiltration, especially with vasopressors.
• Positioning: Position patient to optimize hemodynamics (supine with legs elevated for hypovolemic shock; semi-Fowler's for cardiogenic shock with pulmonary edema). Reposition carefully to prevent sudden hemodynamic changes.
• Temperature Management: Monitor core temperature and prevent hypothermia, which worsens coagulopathy and cardiac function. Use warming devices for hypothermic patients and cooling measures for hyperthermia.
• Skin Care: Implement pressure injury prevention strategies, as shock patients are at high risk due to tissue hypoperfusion, immobility, and vasopressor use. Perform frequent skin assessments and repositioning.
• Psychological Support: Provide reassurance and clear communication to patient and family. Shock states are frightening for patients who are conscious, and anxiety can worsen tachycardia and oxygen consumption.

Commonly Confused Points

Priority Nursing Actions

• Assessment Priorities: NCLEX frequently tests the nurse's ability to recognize early signs of shock and prioritize assessments. Focus on recognizing compensatory mechanisms (tachycardia, tachypnea) before obvious hypotension develops.
• Intervention Sequencing: Questions often ask about the correct order of interventions. Remember ABC priority: Airway and oxygen first, then circulatory support, followed by specific interventions for the shock type.
• Delegation: Understand which shock management tasks can be delegated to unlicensed assistive personnel (UAP) versus those requiring RN assessment and intervention. Vital signs may be delegated, but interpretation and intervention decisions cannot.
• Communication: NCLEX tests appropriate communication with the healthcare team, including what changes to report immediately versus routine updates. Any acute change in vital signs, mental status, or urine output should be reported immediately.

Study Tips & Memory Aids

Common Pitfalls

• Focusing Only on Blood Pressure: A common error is focusing exclusively on blood pressure without assessing other perfusion parameters. Normal blood pressure can mask compensated shock, especially in previously hypertensive patients.
• Excessive Fluid Administration: Continuing aggressive fluid resuscitation without reassessing for signs of fluid overload can lead to pulmonary edema, especially in cardiogenic shock or patients with renal or cardiac dysfunction.
• Delayed Vasopressor Initiation: Waiting too long to start vasopressors in patients with profound hypotension can lead to prolonged organ hypoperfusion. Vasopressors should be started if hypotension persists after initial fluid resuscitation or immediately if severe hypotension threatens vital organ perfusion.
• Misidentifying Shock Type: Incorrectly identifying the shock type can lead to inappropriate interventions. For example, large fluid boluses beneficial in hypovolemic shock may be detrimental in cardiogenic shock.
• Neglecting the Underlying Cause: Focusing only on supporting blood pressure without addressing the underlying cause (e.g., controlling bleeding, treating infection, relieving cardiac tamponade) can lead to continued deterioration.